Feature | November 07, 2013

Cedars-Sinai Heart Institute Patient First in United States to Receive Newly Approved Device to Repair Leaking Mitral Valve

heart valve repair structural cath lab mitraclip abbott vascular sinai

Cedars-Sinai Heart Institute mitral valve patient Pearl Segal, 83, celebrates a successful outcome with her family and healthcare team. From left to right: David Segal, son Saibal Kar, M.D., interventional cardiologist Zalman Segal, husband Asma Hussaini, M.S., PA-C., senior physician assistant

November 7, 2013 — A Cedars-Sinai Heart Institute patient became the first in the nation to undergo the newly approved non-surgical procedure to fix their leaky and life-threatening heart valve condition.
 
Pearl Segal, 83, of Phoenix was the first patient in the nation to have the MitraClip procedure following last week’s approval from the U.S. Food and Drug Administration (FDA). Segal was diagnosed two years ago with mitral valve regurgitation
 
Saibal Kar, M.D., director, Cardiovascular Intervention Center, Sinai Heart Institute, performed the procedure. Kar has performed more MitraClip procedures than any other U.S. physician, according to manufacturer Abbott.
 
Before undergoing the procedure, Segal would lose breath by walking down the hall of her home. Just hours after her 45-minute mitral valve procedure on Nov. 4, Segal’s son David said, “Her color is better, she’s not getting out of breath and she’s smiling.”
 
Pearl Segal said undergoing the mitral procedure was much easier than her 2009 experience with open-heart surgery to fix an unrelated heart condition. That surgery required 10 days of hospitalization followed by two weeks of cardiac rehabilitation and a month of in-home nursing. Because of Segal’s frailty and other health conditions, she was not a candidate for open-heart valve repair.
 
“Mitral valves can become dysfunctional for several reasons, including age,” said Kar. “But, as we age, we face higher risk from open heart surgery. Catheter-based, minimally invasive heart procedures are a way we can add years to life and life to years.”
 
During clinical trials, Kar and other Cedars-Sinai Heart Institute physicians performed more catheter-based mitral valve repairs than any other U.S. medical center. Kar receives compensation from Abbott for teaching clinicians how to implant the MitraClip device.
 
During the procedure, the MitraClip device is delivered to the heart through the femoral vein, a blood vessel in the leg, and once implanted, allows the mitral valve to open and close correctly without leaking, thereby relieving symptoms and improving patient quality of life. Patients undergoing MitraClip treatment typically experience short recovery times and hospital stays.
 
"This device offers new hope for thousands of patients with leaky valves worldwide,” said Eduardo Marbán, M.D., Ph.D., director, Cedars-Sinai Heart Institute. “We are proud to have been the leading site in the clinical trials that led to approval, and we look forward to offering this innovative therapy to all those in need."
 
For more information: www.cedars-sinai.edu, www.abbottvascular.com

Related Content

Videos | Heart Valve Technology | July 10, 2018
Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses t
Videos | Heart Valve Technology | July 05, 2018
Rebecca Hahn, M.D., professor of medicine and director of interventional echocardiography, Columbia University Medica
Henry Ford Hospital First in Michigan to Perform Cardioband Mitral Valve Procedure

An angiography image showing the catheter-based implantation of the Cardioband annuloplasty ring using corkscrew shaped anchors.

News | Heart Valve Technology | June 13, 2018
Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to repair a leaky...
Abbott Portico transcatheter aortic valve replacement (TAVR) performed well PORTICO I real-world study. #EuroPCR
News | Heart Valve Technology | June 01, 2018
June 1, 2018 –  Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with e
Tendyne Transcatheter Mitral Valve Replacement Device Demonstrates Positive 30-Day Outcomes
News | Heart Valve Technology | May 25, 2018
Abbott announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne Transcatheter...
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.

A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital. 

Feature | Heart Valve Technology | May 14, 2018
May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femor
The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak.  #SCAI, #SCAI2018

The use of 3-D printed hearts from patients' pre-TAVR planning CT scans have improved outcomes of procedures at the University of Minnesota. Clearly identifying where calcium is located on the valves prior to TAVR device implantation has helped reduce the incidence of paravalvular leak.

News | Heart Valve Technology | May 14, 2018
May 14, 2018 – A new study examines the effectiveness of 3-D printing technology and computer modeling to predict par
First-Ever Risk Tool Helps Predict TAVR Readmission Rates in 2018 SCAI late-breaking study. #SCAI, #SCAI2018
News | Heart Valve Technology | May 11, 2018
A new study looked at the effectiveness of a novel risk tool to predict 30-day readmission rates in patients undergoing...
Medtronic Shares Two-Year Harmony Transcatheter Pulmonary Valve Results at SCAI 2018. #SCAI, #SCAI2018
News | Heart Valve Technology | May 11, 2018
Medtronic plc announced two-year outcomes for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
Colibri Heart Valve Continues Enrollment in TAVI Early Feasibility Study
News | Heart Valve Technology | May 07, 2018
Colibri Heart Valve LLC announced the Colibri transcatheter aortic valve implantation (TAVI) System has been used on an...
Overlay Init